الملخص
Two infants with retinoblastoma and 13q syndrome with multiorgan system anomalies were treated with targeted intra-arterial chemotherapy (IAC) using one-to-three cycles of melphalan 5 mg to avoid systemic chemotherapeutic side effects. Both patients showed good response, with tumor control and no systemic chemotherapy side effects. Of the treatment modalities currently available, IAC may represent an optimal balance between tumor extermination and adverse drug reactions in this patient population with classically reduced multiorgan reserve.
الكلمات المفتاحية
بيانات النشر
- المعرّف الرقمي
- 10.4103/0974-620x.192278
- المجلة
- المجلة العُمانية لطب العيون, 9(3), 164-166
- الناشر
- منشورات ميدنو
- وصول مفتوح
- وصول مفتوح ذهبي
اقتبس هذه المقالة
APA 7
Dillon, A. B., Douglass, A., Jabbour, P., & Shields, C. L. (2016). Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome. Oman Journal of Ophthalmology, 9(3), 164-166. https://doi.org/10.4103/0974-620x.192278
MLA 9
Dillon, Alexander B, et al. "Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome." Oman Journal of Ophthalmology, vol. 9, no. 3, 2016, pp. 164-166. https://doi.org/10.4103/0974-620x.192278.
شيكاغو (المؤلف–التاريخ)
Dillon, Alexander B, Alexzandra Douglass, Pascal Jabbour, and Carol L Shields. 2016. "Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome." Oman Journal of Ophthalmology 9 (3): 164-166. https://doi.org/10.4103/0974-620x.192278.
هارفارد
Dillon, A. B., Douglass, A., Jabbour, P. and Shields, C. L. (2016) 'Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome', Oman Journal of Ophthalmology, 9(3), pp. 164-166. doi:10.4103/0974-620x.192278.
فانكوفر
Dillon AB, Douglass A, Jabbour P, Shields CL. Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome. Oman Journal of Ophthalmology. 2016;9(3):164-166. doi:10.4103/0974-620x.192278
IEEE
A. B. Dillon, A. Douglass, P. Jabbour, and C. L. Shields, "Minimal exposure intra-arterial chemotherapy for children with retinoblastoma and 13q syndrome," Oman Journal of Ophthalmology, vol. 9, no. 3, pp. 164-166, 2016, doi: 10.4103/0974-620x.192278.